Table 3. Metabolic Syndrome Prevalence in PCOS Subgroups and Controls (NCEP ATP III, and IDF Criteria).
| Parameters | IM+HA+PCO (n = 181) | HA+PCO (n = 23) | Controls (n = 204) |
|---|---|---|---|
| WC a ≥ 88 cm/ ≥ 80 cm | 94/145 | 08/17 | 08/45 |
| TG ≥ 1.7 mmol/L (150 mg/dL) | 50 | 03 | 20 |
| HDL ≤ 1.3 mmol/L (50 mg/dL) | 163 | 21 | 160 |
| BP ≥ 130/85 mmHg | 18 | 04 | - |
| FB glucose > 6.1 mmol/L (101 mg/dL) | 15 | 02 | - |
| No of subjects fulfilling the criteria | 50 (28%) | 03 (13%) | 08 (4%)/20 (10%) |
a Abbreviations: MetS, Metabolic Syndrome; PCOS, Polycystic Ovarian Syndrome; NCEP ATP III, National Cholesterol Education Program Adult Treatment Plan III; IDF, International Diabetes Federation; IM, Irregular Menstruation; HA, Hyperandrogenism; PCO, Polycystic Ovary; WC, Waist Circumference; TG, Triglycerides; HDL, High Density Lipoprotein; FBG, Fasting Blood Glucose.